Видео ютуба по тегу Exdensur

FDA Approves Exdensur: The First Twice Yearly Biologic for Severe Asthma Attacks
FDA Approves Exdensur: The First Twice Yearly Biologic for Severe Asthma Attacks
Five Things Must Know for Exdensur (Depemokimab)!
Five Things Must Know for Exdensur (Depemokimab)!
Тяжелая эозинофильная астма? Представляем EXDENSUR — новое средство лечения!
Тяжелая эозинофильная астма? Представляем EXDENSUR — новое средство лечения!
Страдаете от тяжелой формы астмы? Инъекция ЭКСДЕНСУР (депемокимаб-ула).
Страдаете от тяжелой формы астмы? Инъекция ЭКСДЕНСУР (депемокимаб-ула).
FDA Approves GSK's Exdensur: Twice-Yearly Shot Revolutionizes Severe Asthma Care
FDA Approves GSK's Exdensur: Twice-Yearly Shot Revolutionizes Severe Asthma Care
Exdensur: A Breakthrough Treatment for Asthma and Chronic Rhinosinusitis
Exdensur: A Breakthrough Treatment for Asthma and Chronic Rhinosinusitis
Exdensur (depemokimab): FDA Approval for Severe Asthma — What It Means
Exdensur (depemokimab): FDA Approval for Severe Asthma — What It Means
GSK Exdensur Approval and Biologic Market Dynamics
GSK Exdensur Approval and Biologic Market Dynamics
GSK's New Asthma Drug: A Game-Changer for Patients
GSK's New Asthma Drug: A Game-Changer for Patients
FDA Approved Asthma Injection Explained | Exdensur (depemokimab-ulaa) | Pharmacist Review
FDA Approved Asthma Injection Explained | Exdensur (depemokimab-ulaa) | Pharmacist Review
New Breakthrough Asthma Drug (depemokimab) Explained
New Breakthrough Asthma Drug (depemokimab) Explained
FDA Approves Exdensur for Severe Asthma: New Biologic Treatment Explained
FDA Approves Exdensur for Severe Asthma: New Biologic Treatment Explained
Одобрение препарата Exdensur Depemokimab в Великобритании: прорыв в лечении астмы и полипов носа.
Одобрение препарата Exdensur Depemokimab в Великобритании: прорыв в лечении астмы и полипов носа.
В Великобритании одобрен биологический препарат для лечения астмы и хронического риносинусита с п...
В Великобритании одобрен биологический препарат для лечения астмы и хронического риносинусита с п...
EXDENSUR (depemokimab) Approved as an Injectable Ultra-Long-Acting Therapy for Severe Asthma
EXDENSUR (depemokimab) Approved as an Injectable Ultra-Long-Acting Therapy for Severe Asthma
This New Asthma Treatment Only Needs 2 Doses Per Year? (Dipimokimab)
This New Asthma Treatment Only Needs 2 Doses Per Year? (Dipimokimab)